- Home
- AMLX vs LADR Comparison
AMLX vs LADR Comparison
Compare AMLX & LADR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AMLX | LADR |
|---|---|---|
| Founded | 2014 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.3B |
| IPO Year | 2021 | 2013 |
Fundamental Metrics
Financial Performance| Metric | AMLX | LADR |
|---|---|---|
| Price | $13.37 | $10.02 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 2 |
| Target Price | ★ $21.56 | $12.25 |
| AVG Volume (30 Days) | ★ 979.0K | 626.1K |
| Earning Date | 05-07-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 8.98% |
| EPS Growth | ★ 65.46 | N/A |
| EPS | N/A | ★ 0.02 |
| Revenue | ★ $380,786,000.00 | N/A |
| Revenue This Year | N/A | $31.66 |
| Revenue Next Year | N/A | $16.92 |
| P/E Ratio | ★ N/A | $509.00 |
| Revenue Growth | ★ 1612.94 | N/A |
| 52 Week Low | $4.76 | $9.61 |
| 52 Week High | $18.61 | $11.92 |
Technical Indicators
Market Signals| Indicator | AMLX | LADR |
|---|---|---|
| Relative Strength Index (RSI) | 38.47 | 46.58 |
| Support Level | $12.19 | $9.90 |
| Resistance Level | $15.37 | $10.30 |
| Average True Range (ATR) | 0.65 | 0.14 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 40.53 | 45.88 |
Price Performance
Historical ComparisonAbout AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on developing novel therapies for communities with high unmet medical needs. The company has preclinical and clinical development programs in endocrine conditions and neurodegenerative diseases. Its pipeline includes investigational therapies matched with diseases based on mechanistic rationale, clinical outcomes, biomarkers, and preclinical data. The company is currently developing avexitide for Post-Bariatric Hypoglycemia, AMX0035 for Wolfram Syndrome, AMX0114 for Amyotrophic Lateral Sclerosis, and AMX0318 for Post-Bariatric Hypoglycemia and other rare diseases.
About LADR Ladder Capital Corp
Ladder Capital Corp is an internally-managed real estate investment trust that is in commercial real estate finance. The company originates and invests in a diverse portfolio of commercial real estate and real estate-related assets, focusing on senior secured assets. The company's investment activities include: (i) Primary business of originating senior first mortgage fixed and floating rate loans collateralized by commercial real estate with flexible loan structures; (ii) owning and operating commercial real estate, including net leased commercial properties; and (iii) investing in investment-grade securities secured by first mortgage loans on commercial real estate. The company has three reportable segments: Loans, which derive maximum revenue; Securities; and Real Estate.